While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

For those who have been prescribed weight loss or diabetes management drugs, like Ozempic, a new warning has been issued.

Australia’s TGA has issued updated safety warnings for GLP-1 drugs like Ozempic and Mounjaro, highlighting mental-health ...

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...

Australia's medicines regulator issues a safety warning over the potential risk of suicidal thoughts and behaviours when ...

Australia's Therapeutic Goods Administration has issued new safety warnings about mental health risks and contraception ...

New precautions added for GLP-1 drugs as reports of mood changes and contraceptive concerns emerge in Australia.

The Australian Therapeutic Goods Administration (TGA) has updated its product warnings on the class of weight loss and ...

The EMA (European Medicines Agency), FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other ...

A trial of Eli Lilly and Co.’s blockbuster diabetes drug Mounjaro fell short of expectations that it would do a better job of preventing heart attacks and strokes than its older medicine Trulicity.

A rising number of Ozempic gastroparesis lawsuits are being filed across the United States, alleging that the popular diabetes and weight-loss drug has caused patients to develop severe stomach ...

A new study reported that Novo Nordisk spent $7.5 million over 2 years on more than 15,000 internet keywords — many focused ...